Diabetes Care Devices are used in the treatment and management of diabetes. Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below. An Insulin Pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. Continuous Glucose Monitoring System is used for the continuous measurement of blood glucose. GlobalData uses proprietary data and analytics to provide a comprehensive report on the insulin pumps & continuous glucose monitors market in Portugal. Buy the latest report here.

In 2023, GlobalData’s Market Model methodology determined that the leading player in the insulin pumps & continuous glucose monitors market in Portugal was Abbott Laboratories followed by Medtronic, F. Hoffmann-La Roche, DexCom, Ypsomed and Senseonics.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

An Insulin Pump consists of a battery-run pump, an insulin reservoir, and an infusion set with a tubing system for subcutaneous intervention. Traditional Insulin Pumps & Accessories and Patch Pumps are included in Insulin Pumps. The Continuous Glucose Monitoring System includes an implantable sensor with wireless transmission capability and a monitor.

The insulin pumps & continuous glucose monitors market in Portugal can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size insulin pumps & continuous glucose monitors in Portugal, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.